You are here

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Ocular adverse events in PD-1 and PD-L1 inhibitors

 

Online download statistics by month:

Online download statistics by month: July 2021 to January 2026

AbstractFullPdf
Jul 2021476476152
Aug 202114314335
Sep 202112012037
Oct 202113213233
Nov 2021999926
Dec 2021909124
Jan 202211511825
Feb 2022686934
Mar 202212712852
Apr 202214515341
May 202211611837
Jun 202212713147
Jul 202213613730
Aug 202214714836
Sep 202211111431
Oct 202214519169
Nov 202210010028
Dec 202211211224
Jan 202311711828
Feb 202315115131
Mar 202310610626
Apr 2023919140
May 2023919224
Jun 202312012240
Jul 202310310334
Aug 2023979929
Sep 2023828531
Oct 2023909025
Nov 202312512741
Dec 202311411444
Jan 2024424323
Feb 2024656637
Mar 202415115264
Apr 2024999937
May 2024747432
Jun 2024848938
Jul 202410510730
Aug 2024767726
Sep 2024777735
Oct 202410410533
Nov 2024687827
Dec 2024798031
Jan 202515015228
Feb 2025646525
Mar 2025666636
Apr 202510810884
May 202512312537
Jun 2025707429
Jul 2025110
Aug 2025110
Jan 2026110
Total540455181806